BioCentury
ARTICLE | Clinical News

Xpansion Interpreter regulatory update

July 21, 2014 7:00 AM UTC

Asuragen said the New York State Department of Health issued a clinical laboratory permit for its Xpansion Interpreter and miRInform Thyroid tests. Xpansion Interpreter determines the total number of CGG repeats and number of AGG interruptions in the Fragile X mental retardation 1 (FMR1) gene and can be used in determining the risk of having a child with Fragile X syndrome. ...